Myers Michael 4/A
4/A · Quoin Pharmaceuticals, Ltd. · Filed Jun 13, 2025
Insider Transaction Report
Form 4/AAmended
Myers Michael
DirectorChief Executive Officer
Transactions
- Award
Share Option (Right to Buy)
2025-05-29+42,857→ 42,857 totalExercise: $9.07Exp: 2035-05-29→ ADS (42,857 underlying)
Footnotes (2)
- [F1]The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"). Each ADS represents thirty-five ordinary shares of the Issuer. On June 2, 2025, the reporting person filed a Form 4 which inadvertently understated the number of ADSs underlying the option granted to the reporting person on May 29, 2025.
- [F2]The option vests in four annual installments with 20% vesting on each of May 29, 2026, 2027 and 2028 and 40% vesting on May 29, 2029.